Serum levels of galactose-deficient IgA are elevated in patients with IgA nephropathy but do not correlate to disease activity or progression

被引：0
|
作者：
Sigridur Elíasdóttir
Alina Khramova
Aso Saeed
Gregor Guron
Roberto Boi
Johan Mölne
Kerstin Ebefors
Jenny Nyström
机构：
[1] The Sahlgrenska Academy at the University of Gothenburg,Department of Molecular and Clinical Medicine/Nephrology, Institute of Medicine
[2] The Sahlgrenska Academy at the University of Gothenburg,Department of Physiology, Institute of Neuroscience and Physiology
[3] University of Gothenburg,Institute of Biomedicine, Department of Laboratory Medicine
来源：
BMC Nephrology | / 24卷
关键词：
IgA nephropathy; Chronic kidney disease; Prognosis; Biomarkers; Albuminuria; Gd-IgA;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Treatment With Nefecon Reduces Circulating Levels of Galactose-Deficient IgA1 in Patients With IgA Nephropathy in the NefIgArd Clinical Trial
    Molyneux, Karen
    Nawaz, Nadia
    Taylor, Scott
    Barratt, Jonathan
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 783 - 784
  • [42] A case of paraneoplastic IgA nephropathy with glomerular capillary IgA and galactose-deficient IgA1 deposition
    Isogai, Erika
    Iwazu, Yoshitaka
    Akimoto, Tetsu
    Kuro-o, Makoto
    Niki, Toshiro
    Nagata, Daisuke
    CEN CASE REPORTS, 2024, 13 (02) : 104 - 109
  • [43] Clinical Significance of Galactose-Deficient IgA1 by KM55 in Patients with IgA Nephropathy
    Zhang, Kai
    Li, Qiongqiong
    Zhang, Yaru
    Shang, Wenya
    Wei, Li
    Li, Hongfen
    Gao, Shan
    Yan, Tiekun
    Jia, Junya
    Liu, Youxia
    Lin, Shan
    KIDNEY & BLOOD PRESSURE RESEARCH, 2019, 44 (05): : 1196 - 1206
  • [44] A case of paraneoplastic IgA nephropathy with glomerular capillary IgA and galactose-deficient IgA1 deposition
    Erika Isogai
    Yoshitaka Iwazu
    Tetsu Akimoto
    Makoto Kuro-o
    Toshiro Niki
    Daisuke Nagata
    CEN Case Reports, 2024, 13 : 104 - 109
  • [45] Serum galactose-deficient IgA1 level changes depending on the degree of immunosuppression in IgA nephropathy patients after kidney transplantation
    Kim, M. J.
    Schaub, S.
    Molyneux, K.
    Barratt, J.
    Koller, M.
    Jehle, A.
    Steiger, J.
    SWISS MEDICAL WEEKLY, 2013, 143 : 5S - 5S
  • [46] ELL2 Is Downregulated and Associated with Galactose-Deficient IgA1 in IgA Nephropathy
    Liu, Youxia
    Zheng, Jie
    Zhao, Na
    Jia, Junya
    Yan, Tiekun
    DISEASE MARKERS, 2019, 2019
  • [47] Clinical Relevance of Serum Galactose Deficient IgA1 in Patients with IgA Nephropathy
    Kim, Jin Sug
    Hwang, Hyeon Seok
    Lee, Sang Ho
    Kim, Yang Gyun
    Moon, Ju-Young
    Kong, Ji Yoon
    Jeong, Kyung Hwan
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (11) : 1 - 11
  • [48] Mesangial cells from patients with IgA nephropathy have increased susceptibility to galactose-deficient IgA1
    Ebefors, Kerstin
    Liu, Peidi
    Lassen, Emelie
    Elvin, Johannes
    Candemark, Emma
    Levan, Kristina
    Haraldsson, Borje
    Nystrom, Jenny
    BMC NEPHROLOGY, 2016, 17
  • [49] Mesangial cells from patients with IgA nephropathy have increased susceptibility to galactose-deficient IgA1
    Kerstin Ebefors
    Peidi Liu
    Emelie Lassén
    Johannes Elvin
    Emma Candemark
    Kristina Levan
    Börje Haraldsson
    Jenny Nyström
    BMC Nephrology, 17
  • [50] Characterization of a recombinant IgG autoantibody specific for galactose-deficient IgA1 in IgA nephropathy
    Knoppova, Barbora
    Hansen, Alyssa
    Moldoveanu, Zina
    Hall, Stacy D.
    Huang, Zhi-Qiang
    Novak, Lea
    Julian, Bruce A.
    Renfrow, Matthew B.
    Novak, Jan
    Green, Todd J.
    GLYCOBIOLOGY, 2020, 30 (12) : 1068 - 1068
12345